Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

NGNENGNE
Showing 8 of 11 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in NEUROGENE INC

GEODE CAPITAL MANAGEMENT, LLC holds 293,182 shares of NGNE (NEUROGENE INC), worth $9.2M as of 2026-Q2. The position was increased (+5.1% shares). NGNE represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$9.2M

Current Shares

293,182

Total Value Change

-$35,407

Total Shares Change

+72,583

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
293,182
+5.1%
$9.2M0.0%$31.45
29
2026-Q1
Increased
279,003
+11.7%
$5.6M0.0%$21.99
30
2025-Q4
Increased
249,695
+1.3%
$5.1M0.0%$22.11
27
2025-Q3
Decreased
246,433
-0.5%
$4.3M0.0%$17.71
0
2025-Q2
Decreased
247,775
-4.5%
$3.7M0.0%$16.16
0
2025-Q1
Increased
259,376
+10.6%
$3M0.0%$14.52
29
2024-Q4
Increased
234,625
+6.4%
$5.4M0.0%$22.28
29
2024-Q3
Decreased
220,599
-0.7%
$9.3M0.0%$40.33
0

Other major holders of NGNE: BlackRock Finance, Inc., RTW INVESTMENTS, LP, Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used